Takeda Adcertris combo approved by European Commission for newly diagnosed Stage IIb/III/IV Hodgkin Lymphoma
Osaka: Takeda has received approval from the European Commission (EC) for ADCETRIS (brentuximab vedotin) in combination with etoposide, cyclophosphamide, doxorubicin, dacarbazine and dexamethasone...